ipamorelin do – Research Peptide Ipamorelin: The Ultimate Growth Hormone-Releasing

Dual-peptide secretagogue formulation for GH axis research CJC-1295: studied for GHRH signal amplification and extended half-life Ipamorelin: selective ghrelin-receptor agonist with minimal cortisol/prolactin effects Balanced delivery of both peptides in each application Pre-filled pen format for precise, repeatable volume delivery in research applications What Researchers Say Frequently Asked Questions A dual formulation of Ipamorelin (a selective GHSR-1a agonist) and CJC-1295 (a GHRH analogue), both studied in growth-hormone-axis research

Headache: Some users report mild to moderate headaches, usually subsiding within a few hours

Who Should Avoid GHRP-6 Some groups should not use GHRP-6 without close medical guidance, mainly because growth hormone affects blood sugar and because of its unproven long-term safety

In research, this combination is sometimes studied with the PCB-157 (tissue regeneration), the Tesamoreline (approved GHRH analogue), or the GHRP-2 to explore different GH axis stimulation configurations

1- Muscle growth and recovery: CJC-1295 produces sustained increases in GH and IGF-1, both of which are essential for protein synthesis and tissue repair 3 , thereby supporting lean muscle gains and facilitating faster post-exercise recovery